U.S. Life Sciences Stock News

Generate Biomedicines completed its U.S. IPO and began trading on Nasdaq under the symbol GENB. The company adopted a new certificate of incorporation in connection with its transition to public status. Generate Biomedicines joined the NASDAQ Composite Index following the offering. The IPO involved a substantial capital raise intended to support the company’s future plans. Generate Biomedicines, now trading as NasdaqGS:GENB, has moved into the public markets with a current share price of...

Micron Technology (MU) is back in focus after a sharp sector wide selloff tied to fears of higher energy costs and Iran related tensions, which pressured memory names despite ongoing AI centric demand stories. See our latest analysis for Micron Technology. Despite the latest pullback tied to energy concerns and geopolitical tensions, Micron’s recent share price performance has been strong, with a 90 day share price return of 67.38% and a very large 1 year total shareholder return of 328.52%...

Insider buying puts Vornado Realty Trust (VNO) back in focus Recent filings show Director Daniel R Tisch buying 155,000 Vornado Realty Trust (VNO) shares across several late February and early March trades, lifting his direct holdings to 185,000 shares. This cluster of insider purchases, set against mixed analyst opinions and recent share price pressure, gives investors fresh information to weigh as they assess Vornado’s office- and retail-focused REIT portfolio. See our latest analysis for...

Leidos Holdings (LDOS) is back in focus after the U.S. Air Force formally designated its Small Cruise Missile as the AGM-190A, with investors weighing what this recognition could mean for long-term contract visibility. See our latest analysis for Leidos Holdings. Recent defense contract wins and the DODNet rollout have arrived during a pullback, with a 30 day share price return of a 7.45% decline and a year to date share price return of a 4.26% decline. However, the 1 year total shareholder...

If you are wondering whether Walmart's share price still offers value after a long run, this article walks through what the current market price might be implying about the company. Walmart closed at US$123.31, with a 0.9% decline over 7 days, a 3.4% decline over 30 days, a 9.4% gain year to date and a 31.5% return over the last year, while the 3 year and 5 year returns are both very large. Recent headlines around Walmart have focused on its role as a major US retailer and its scale in key...

Why Acadia Realty Trust Is On Investors’ Radar Acadia Realty Trust (AKR) has drawn fresh attention after recent trading saw the stock up around 7% over the past month and roughly 9% in the past 3 months. For real estate investors watching listed retail landlords, those moves, combined with Acadia’s latest annual figures, raise questions about how its income profile, balance between revenue and net income, and current valuation might fit into a diversified income focused portfolio. See our...

Korn Ferry (NYSE:KFY) has approved a significant increase in its quarterly cash dividend. The higher payout will apply to upcoming dividend distributions following the board’s decision. This move directly affects income for shareholders who hold NYSE:KFY. The dividend hike comes as Korn Ferry shares trade around $65.08, with the stock up 3.4% over the past week and showing a 22.7% return over the past 3 years. The company’s value score of 6 may be relevant to investors who focus on...

Deutsche Bank’s upgrade of Dauch (DCH) from Hold to Buy, together with a shift in consensus brokerage views to Outperform, has put the stock back on many investors’ radars this week. See our latest analysis for Dauch. Even with Deutsche Bank’s upgrade and the recent RSU grants tied to the Dowlais combination, Dauch’s 1 month share price return of 28.95% and 7 day share price return of 13.74% indicate momentum has cooled recently. However, its 1 year total shareholder return of 21.92%...

In recent months, Crane NXT reported solid operating results and advanced the first phase of its Antares Vision acquisition, while also facing a reduced full-year earnings outlook amid renewed trade tensions with China and macro uncertainty in its Payment Innovations segment. This combination of cautious guidance and geopolitical risk contrasts with ongoing momentum in Security & Authentication Technologies and an expansion into life sciences and food & beverage markets, creating a more...

TG Therapeutics (TGTX) is back in focus after management reaffirmed its 2026 revenue guidance for BRIUMVI, highlighted rapid physician uptake in multiple sclerosis, and noted a busy schedule of pipeline readouts in the coming years. See our latest analysis for TG Therapeutics. Despite strong 2025 results and the recent azer cel milestone, TG Therapeutics’ 7 day share price return of 6.05% and 90 day share price return of 5.62% point to fading near term momentum, while the 3 year total...

Without a specific news headline driving attention today, Diamondback Energy (FANG) is on investors’ radar as an established Permian Basin producer with shares recently closing at $179.04 and a one year total return of 31.47%. See our latest analysis for Diamondback Energy. The recent 7.22% 7 day share price return and 9.92% 30 day share price return hint that positive momentum is building on top of a 31.47% 1 year total shareholder return and stronger multi year gains. If Diamondback’s run...

Why Patterson-UTI Energy is on investors’ radar today Patterson-UTI Energy (PTEN) has drawn attention after recent trading left the shares at US$8.84, with returns of 13.2% over the past month and 39.9% over the past 3 months. See our latest analysis for Patterson-UTI Energy. The recent 7 day share price return of 5.1% and 3 month share price return of 39.9% put the current US$8.84 level in the context of a strong rebound. However, the 3 year total shareholder return of 25.4% suggests longer...

The Morning Bull - US Market Morning Update Friday, Mar, 6 2026 US stock futures are slightly higher this morning, with E-mini S&P 500 contracts up about 0.1%, as investors weigh a mixed picture on jobs, inflation and interest rates. Economists expect US Nonfarm Payrolls to add just 59,000 jobs in February, with unemployment at 4.3% and monthly wage growth at 0.3%, which in plain terms points to hiring that is slowing but pay packets still edging up. At the same time, US 10 year Treasury...

Merck (NYSE:MRK) has expanded a multi year collaboration with Tempus AI to develop precision medicine biomarkers using advanced AI and machine learning. The company reported positive Phase 3 data for new cancer regimens, including combinations of KEYTRUDA with WELIREG or Padcev in renal and bladder cancers. Together, these updates reflect ongoing activity in Merck’s oncology pipeline and efforts to broaden its cancer portfolio in light of future Keytruda loss of exclusivity. For investors...

In early March 2026, Amgen’s board declared a US$2.52 per-share second-quarter dividend, payable on June 5, 2026, to shareholders of record as of May 15, while the company continued to highlight its broad pipeline and ongoing conference appearances to engage investors and stakeholders. These updates come alongside consistent earnings and revenue beats over the last four quarters, reinforcing Amgen’s image as a company balancing shareholder returns with ongoing investment in future...

Event overview and recent stock move UniFirst (UNF) shares have recently drawn attention after a strong short term move, with the stock up about 13.6% over the past day and roughly 29% over the past month. See our latest analysis for UniFirst. The sharp 1 day share price return of 13.6% sits on top of a strong recent run, with a 30 day share price return of 29.4% and a 1 year total shareholder return of 26.7%. This points to building momentum rather than a one off move. If this kind of move...

Medtronic (MDT) is back on investors’ radar after a series of diabetes focused moves and a fresh dividend decision, tying product launches, a potential MiniMed IPO, and a GE HealthCare partnership into one transformation story. See our latest analysis for Medtronic. Despite the dividend affirmation and recent diabetes initiatives, Medtronic’s share price momentum has been weak. The stock has recorded a 1 month share price decline of 9.86% and a year to date share price decline of 3.16%...

First Financial Bancorp (NasdaqGS:FFBC) has received the Gallup Exceptional Workplace Award for the second year in a row. The award recognizes the company’s high performance culture and strengths based approach to employee engagement. The repeat recognition underscores continued focus on employee development and organizational culture. First Financial Bancorp, the Cincinnati based banking group, operates in a sector where talent, risk management, and relationship driven service are central...

Ares Management (NYSE:ARES) has been highly active in private markets, leading major continuation fund deals and secondary transactions. The firm recently emerged as the primary buyer of a private credit portfolio from Arcmont Asset Management. Ares also completed an $850 million continuation fund deal for Convergint Technologies, extending its role in private equity secondaries. Ares Management focuses on alternative assets across private credit and private equity, which sit at the center...

In February 2026, Martin Marietta Materials updated its 2026 earnings guidance, targeting midpoint revenues of US$7,160 million and 12% volume growth, incorporating expected contributions from the QUIKRETE transaction and Minnesota aggregates and FOB asphalt assets acquired from CRH in late 2025. This guidance update arrives soon after a disappointing Q4 2025 earnings miss and new acquisitions such as Premier Magnesia, highlighting a contrast between recent operational setbacks and...

Oracle is launching a large restructuring plan that includes major layoffs across multiple divisions. The company is cutting thousands of jobs to help fund a rapid build-out of AI data centers. The new AI infrastructure is intended to support clients such as OpenAI, xAI, and Meta. For investors watching NYSE:ORCL, this restructuring lands at a time when the stock trades at $154.79 and has returned 84.7% over 3 years and 145.9% over 5 years. These figures highlight the significance of...

Nelnet, Inc. reported past fourth-quarter 2025 net income of US$57.77 million, down from US$63.16 million a year earlier, while full-year 2025 net income rose to US$428.47 million and basic earnings per share from continuing operations increased to US$11.79. Alongside these results, Nelnet Campus Commerce appointed Evan Claudeanos as managing director of Product and Engineering to lead Project Horizon, a multi-year platform transformation aimed at strengthening its higher education...

Accel Entertainment (ACEL) is back in focus after reporting fourth quarter and full year 2025 results, featuring record revenue, a near doubling of net income, and continued share repurchases that completed a multi year buyback program. See our latest analysis for Accel Entertainment. The earnings release and confirmation of the completed multi year buyback have come after a 90 day share price return of 16.43% and a 1 year total shareholder return of 19.86%. The current share price of $12.19...

Firefly Aerospace postponed its planned Alpha rocket return to flight following a prior mission failure. The delay extends an operational pause that has already lasted about ten months. The company plans to move to an upgraded Block II Alpha configuration after this return to flight mission. For investors watching Firefly Aerospace (NasdaqGM:FLY), the timing of this postponement comes after a tough stretch for the stock. Shares recently closed at $20.38, with a decline of 5.3% over the past...